Truist Securities Downgrades Exelixis to Hold, Raises Price Target to $54
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsDowngradesPrice Target
Truist Securities analyst Gregory Renza downgrades Exelixis (NASDAQ:EXEL) from Buy to Hold and raises the price target from $51 to $54.
Truist Securities analyst Gregory Renza downgrades Exelixis (NASDAQ:EXEL) from Buy to Hold and raises the price target from $51 to $54.